Allspring Global Investments Holdings LLC Invests $5.20 Million in Medpace Holdings, (NASDAQ)
November 8, 2023
🌥️Trending News
Medpace Holdings ($NASDAQ:MEDP), Inc. (NASDAQ) is a globally renowned clinical research organization (CRO) with a specialized focus on providing clinical services for the pharmaceutical, biotechnology, and medical device industries. Recently, Allspring Global Investments Holdings LLC has invested $5.20 Million in Medpace Holdings, Inc. (NASDAQ). Allspring Global Investments Holdings LLC holds an impressive portfolio of stocks and is committed to supporting companies that strive for their vision and mission.
This marks a significant milestone for Medpace Holdings, Inc. as the additional funding will help them build a solid foundation and continue to expand and develop their clinical research services. The funds will also be used to further enhance their global presence in the industry.
Price History
MEDPACE HOLDINGS stock opened at $275.0 and closed at $269.4, down by 1.8% from its previous closing price of 274.2.
However, the news of the investment from Allspring Global Investments Holdings LLC is likely to have a positive effect on the stock price in the near future. The investment will enable Medpace Holdings, Inc. to enhance its already strong position in the industry and further expand its operations. Moreover, the funds will help them acquire new technologies and services that could help them increase their bottom line. Overall, this investment from Allspring Global Investments Holdings LLC is a major boon for Medpace Holdings, Inc., as it will not only help them stay competitive but also allow them to continue grow their operations. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Medpace Holdings. More…
| Total Revenues | Net Income | Net Margin |
| 1.78k | 273 | 15.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Medpace Holdings. More…
| Operations | Investing | Financing |
| 413.66 | -35.85 | -315.29 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Medpace Holdings. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.49k | 1.02k | 15.35 |
Key Ratios Snapshot
Some of the financial key ratios for Medpace Holdings are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 25.7% | 30.1% | 17.7% |
| FCF Margin | ROE | ROA |
| 21.2% | 45.6% | 13.2% |
Analysis
As GoodWhale, we conducted an analysis of MEDPACE HOLDINGS‘s wellbeing. Our results indicated that MEDPACE HOLDINGS is strong in growth and profitability, but weak in asset and dividend, as seen on our Star Chart. Based on this assessment, we classified MEDPACE HOLDINGS as a ‘gorilla’, a type of company that has achieved stable and high revenue or earning growth due to its strong competitive advantage. This makes MEDPACE HOLDINGS an attractive company for investors who are looking for stable returns. We also evaluated MEDPACE HOLDINGS’ health score of 8/10 with regards to its cashflows, indicating that it is capable of paying off debt and funding future operations. This stability also makes MEDPACE HOLDINGS an attractive investment opportunity. More…
Peers
Medpace’s services include clinical trial management, data management, biostatistics, and medical writing. Medpace’s competitors include Icon PLC, Syneos Health Inc, and IQVIA Holdings Inc.
– Icon PLC ($NASDAQ:ICLR)
Icon PLC is a publicly traded company with a market capitalization of $14.59 billion as of March 2022. The company has a return on equity of 4.28%. Icon is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company has a network of over 80 sites in 40 countries. Icon’s services include clinical research, regulatory affairs, quality management, data management, and biostatistics.
– Syneos Health Inc ($NASDAQ:SYNH)
Synoes Health Inc is a pharmaceutical company with a market cap of 4.81B as of 2022. The company has a Return on Equity of 9.89%. The company develops, manufactures, and sells pharmaceutical products. The company’s products include prescription drugs, over-the-counter drugs, and medical devices. The company operates in the United States, Europe, and Asia.
– IQVIA Holdings Inc ($NYSE:IQV)
IQVIA Holdings Inc is a global healthcare company that provides market research, data, and analytics solutions to help customers drive healthcare transformation and growth. The company’s market cap as of 2022 is 33.49B, and its ROE is 19.29%. IQVIA’s customers include healthcare payers and providers, pharmaceutical and biotech companies, and government agencies. The company’s solutions help its customers drive healthcare transformation by improving patient outcomes, reducing costs, and increasing access to care.
Summary
Medpace Holdings, Inc. (NASDAQ: MEDP) has been a focus of investment recently, with Allspring Global Investments Holdings LLC having declared a $5.20 million stake in the company. With its promising fundamentals, MEDPACE looks like an attractive opportunity for investors.
Related Posts
Recent Posts
